Drug-Eluting Device Market Analysis| 2025-2030

Attractive Opportunities

Global Demand Analysis & Sales Opportunities in Drug-Eluting Device Market

• The annual demand for drug-eluting device was USD 3.4 billion in 2024 and is expected to reach USD 3.6 billion in 2025, up 6.5% than the value in 2024.
• During the forecast period (2025 to 2030), the drug-eluting device market is expected to grow at a CAGR of 5.7%. The annual demand will reach of USD 4.9 billion in 2030.
• During 2025-2030, the drug-eluting device industry is expected to generate a cumulative sales opportunity of USD 25.58 billion.
   

Want to know more about the market scope? Register Here
 

High-Growth Market Segments:

• North America is expected to maintain its reign over the forecast period, whereas Asia-Pacific is likely to grow at the fastest rate. 
• By Degradability type, Biodurable is likely to be the dominant type in the market during the forecast period.
• By Application type, Coronary Stents are likely to maintain their market dominance in the coming years
• By End-Use type, Hospitals are expected to remain the biggest demand generator in the market during the forecast period.

Market Statistics

Have a look at the sales opportunities presented by the drug-eluting device market in terms of growth and market forecast.

Market Dynamics

Introduction:

What is a drug-eluting device?

Drug-eluting devices are medical implants or devices that release therapeutic drugs over time while maintaining their structural integrity and functionality within the body for an extended period. These devices do not degrade and hence are required to be removed once the functionality of the implant is achieved.

These devices also help prevent restenosis (overgrowth of scar tissue). Polyurethane (PU), ethylene-vinyl acetate (EVA), and silicone are the common polymer materials used in coating the scaffold of these devices.

Segment AnalysisSegments Analysis

By Application Type

“Coronary stents are expected to remain dominant, whereas balloons will be the fastest-growing application type in the market during the forecast period.”

• The global drug-eluting device market is segmented into coronary stents, balloons, and periphery stents.
• Coronary stents are used mainly for coronary artery diseases, and there is a rising demand for these stents due to their prevalent use in preventing restenosis.
• Balloons are new products in the current market and are in the early stages of development in the market. These products show better results in the prevention of restenosis for coronary diseases when compared to stents.
   

To get the full scope of the report, Register Here
 

By Degradability Type

“Biodurable is expected to remain dominant in the market, and bioresorbable will be the fastest growing degradable type in the market during the forecast period.”

• The market is segmented into biodurable and bioresorbable.
• The present biodurable drug-eluting devices are highly dominant due to the biocompatibility of the biodurable polymers and are replacing the traditional stents and implants.
• Bioresorbable drug-eluting devices' strong growth is due to their biodegradable materials, which will remove the need for a second surgery to remove stents.

By End-User Type

“Hospital end-users are expected to be dominant in the market, whereas ambulatory surgical centers will be the fastest-growing end-users during the forecast period.”

• The market is segmented into hospitals and ambulatory surgical centers.
• The hospital remains a key end-user market with increasing angioplasty and increasing implant surgeries in hospitals. Also, stents and balloons are mostly used in hospitals.
• Ambulatory surgical centers' strong growth is due to rising demand for urgent treatment.

Regional Analysis

“North America is expected to remain the largest market, whereas Asia-Pacific will be the fastest growing for drug-eluting devices during the forecast period.”

• North America is expected to dominate the market, driven by the market's high maturity and awareness of drug-eluting products. The region has high approval rates as well as the presence of multiple leading manufacturers in the region. Also, the high per-capita income of people in this region will garner considerable demand for these high-cost products.
• Asia-Pacific will grow the fastest due to increasing coronary diseases, especially in countries like China and India, where stent requirements are very high. The region has shown an increased focus on healthcare in the past few years, especially after COVID-19.
   

Know the high-growth countries in this report. Register Here

Competitive Landscape

Most of the major players compete in some of the factors, including price, service offerings, regional presence, etc. The following are the key players in the drug-eluting device market -  

Here is the list of the Top Players (Based on Dominance)

• Boston Scientific Group
• Medtronic Plc
• Abbott Laboratories
• Becton, Dickinson and Company
• Philips Group
• Cordis Corp
• Terumo
• Lepu Medical
• Biotronik SE
• Orbus Neich

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at [email protected]

Recent Developments/Mergers & Acquisitions:

• In 2024, Boston Scientific Corporation announced that the FDA had approved its Agent paclitaxel drug-coated balloon (DCB). This device is intended to address coronary in-stent restenosis. The device got FDA breakthrough device designation back in 2021.
• In 2022, Medtronic Plc. Drug-eluting stent product Onyx Frontier™ received U.S. Food and Drug Administration (FDA) approval. This stent product will be highly useful in the treatment of patients with coronary artery disease. It is made up of BioLinx polymer (a blend of 3 polymers) and Zotarolimus drug.

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept so that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.

The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
• COVID-19 impact and its recovery curve.
• Attractive market segments and associated growth opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing and new players.
• Key success factors.

Market Segmentation

This report studies the market, covering a period of 15 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The drug-eluting device market is segmented into the following categories. 

By Application Type 

• Coronary Stents
• Balloons
• Others

By Degradability Type 

• Biodurable
• Bioresorbable

By End-Use Type 

• Hospitals 
• Ambulatory Surgical Centers

By Region 

• North America (Country Analysis: The USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
• Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific)
• Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

Research Methodology

• This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s global drug-eluting device market realities and future market possibilities for the forecast period. 
• The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market.
• The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
• This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
• More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
• We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Service portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]